Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?

Guusje Vugts*, G.A.P. Nieuwenhuijzen, A.J.G. Maaskant-Braat, Robert J. Schipper, Marjolein L. Smidt

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)E28-E29
JournalAnnals of Surgery
Issue number2
Publication statusPublished - Feb 2016

Cite this